Imperial College London
Alternate

Dr Melody Zhifang Ni

Faculty of Medicine, Department of Surgery & Cancer

Senior Research Fellow
 
 
 
//

Contact

 

+44 (0)20 3312 7657z.ni

 
 
//

Location

 

Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Huddy:2021:10.1136/bmjopen-2020-042944,
author = {Huddy, JR and Ni, MZ and Barlow, J and Hanna, GB},
doi = {10.1136/bmjopen-2020-042944},
journal = {BMJ Open},
pages = {1--9},
title = {Qualitative analysis of stakeholder interviews to identify the barriers and facilitators to the adoption of point-of-care diagnostic tests in the UK.},
url = {http://dx.doi.org/10.1136/bmjopen-2020-042944},
volume = {11},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - OBJECTIVES: This study investigated the barriers and facilitators to the adoption of point-of-care tests (POCTs). DESIGN: Qualitative study incorporating a constant comparative analysis of stakeholder responses to a series of interviews undertaken to design the Point-of-Care Key Evidence Tool. SETTING: The study was conducted in relation to POCTs used in all aspects of healthcare. PARTICIPANTS: Forty-three stakeholders were interviewed including clinicians (incorporating laboratory staff and members of trust POCT committees), commissioners, industry, regulators and patients. RESULTS: Thematic analysis highlighted 32 barriers in six themes and 28 facilitators in eight themes to the adoption of POCTs. Six themes were common to both barriers and facilitators (clinical, cultural, evidence, design and quality assurance, financial and organisational) and two themes contained facilitators alone (patient factors and other (non-financial) resource use). CONCLUSIONS: Findings from this study demonstrate the complex motivations of stakeholders in the adoption of POCT. Most themes were common to both barriers and facilitators suggesting that good device design, stakeholder engagement and appropriate evidence provision can increase the likelihood of a POCT device adoption. However, it is important to realise that while the majority of identified barriers may be perceived or mitigated some may be absolute and if identified early in device development further investment should be carefully considered.
AU  - Huddy,JR
AU  - Ni,MZ
AU  - Barlow,J
AU  - Hanna,GB
DO  - 10.1136/bmjopen-2020-042944
EP  - 9
PY  - 2021///
SN  - 2044-6055
SP  - 1
TI  - Qualitative analysis of stakeholder interviews to identify the barriers and facilitators to the adoption of point-of-care diagnostic tests in the UK.
T2  - BMJ Open
UR  - http://dx.doi.org/10.1136/bmjopen-2020-042944
UR  - https://www.ncbi.nlm.nih.gov/pubmed/33849848
UR  - https://bmjopen.bmj.com/content/11/4/e042944
UR  - http://hdl.handle.net/10044/1/88179
VL  - 11
ER  -
Download